Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2009-04-30
2011-11-08
Haq, Shafiqul (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007100, C436S518000, C436S523000, C530S402000, C530S403000, C530S389600, C530S807000
Reexamination Certificate
active
08053205
ABSTRACT:
Novel conjugates of doxorubicin and novel doxorubicin immunogens derived from the 13 and 14 positions of doxorubicin and antibodies generated by these doxorubicin linked immunogens all of which are useful in immunoassays for the quantification and monitoring of doxorubicin in biological fluids.
REFERENCES:
patent: 5122368 (1992-06-01), Greenfield et al.
patent: 5177016 (1993-01-01), Balsari et al.
patent: 5824805 (1998-10-01), King et al.
patent: 6146658 (2000-11-01), Bosslet et al.
patent: 2002/0119095 (2002-08-01), Gabathuler
patent: 0316776 (1989-05-01), None
patent: 0213843 (2002-02-01), None
Chen et al., “Synthesis of Doxorubicin Conjugates Through Hydrazone Bonds to Melanotransferrin P97,” Synthetic Communications, vol. 33, Issue 14 Jan. 2003 , pp. 2377-2390.
King et al., “Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Linkers: A Novel Method for Increasing the Potency of Doxorubicin Immunoconjugates,” Bioconjugate Chem., 1999, 10 (2), pp. 279-288.
King et al., “Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers: Inhibition of Aggregation by Methoxytriethyleneglycol Chains,” J. Med. Chem., 2002, 45 (19), pp. 4336-4343.
Kratz et al., “Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound,” J Med Chem. Dec. 5, 2002;45(25):5523-33.
Kratz et al., “Preparation, characterization and in vitro efficacy of albumin conjugates of doxorubicin,” Biol Pharm Bull. Jan. 1998;21(1):56-61.
Lau et al., “Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro,” Bioorganic & Medicinal Chemistry vol. 3, Issue 10, Oct. 1995, pp. 1305-1312.
Scott et al., “Synthesis of reagents for the one step incorporation of hydrazide functionality onto the lysine residues of proteins, and their use as linkers for carbonyl containing molecules,”Bioorganic & Medicinal Chemistry Letters vol. 6, Issue 13, Jul. 9, 1996, pp. 1491-1496.
Watanabe et al., “Measurement of Cross-Reactive Properties of Adriamycin Derivatives by the Inhibition Enzyme-Linked Immunosorbent Assay for Adriamycin,” Tokai journal of experimental and clinical medicine 15(4), pp. 327-334, Jul. 1990.
Zhou et al., “Cell-specific delivery of a chemotherapeutic to lung cancer cells,” J Am Chem Soc. Dec. 8, 2004;126 (48):15656-7.
The partial European Search Report by the European Patent Office, issued on Oct. 19, 2010, in the European application No. 10007967.2.
The extended European Search Report by the European Patent Office, issued on Jan. 21, 2009, in the European application No. 06739675.4.
Courtney Jodi Blake
He Shu
Salamone Salvatore J.
Haq Shafiqul
Saladax Biomedical Inc.
LandOfFree
Doxorubicin immunoassay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Doxorubicin immunoassay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Doxorubicin immunoassay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4298349